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Abstract
Aims/hypothesis Numerous new genes have recently been
identified in genome-wide association studies for type 2
diabetes. Most are highly expressed in beta cells and
presumably play important roles in their function. However,
these genes account for only a small proportion of total risk
and there are likely to be additional candidate genes not
detected by current methodology. We therefore investigated
isletsfromthepolygenicNewZealandmouse(NZL)modelof
diet-induced beta cell dysfunction to identify novel genes and
pathways that may play a role in the pathogenesis of diabetes.
Methods NZL mice were fed a diabetogenic high-fat diet
(HF) or a diabetes-protective carbohydrate-free HF diet
(CHF). Pancreatic islets were isolated by laser capture
microdissection (LCM) and subjected to genome-wide
transcriptome analyses.
Results In the prediabetic state, 2,109 islet transcripts were
differentially regulated (>1.5-fold) between HF and CHF
diets. Of the genes identified, 39 (e.g. Cacna1d, Chd2,
Clip2, Igf2bp2, Dach1, Tspan8) correlated with data from
the Diabetes Genetics Initiative and Wellcome Trust Case
Control Consortium genome-wide scans for type 2 diabetes,
thus validating our approach. HF diet induced early
changes in gene expression associated with increased cell-
cycle progression, proliferation and differentiation of islet
cells, and oxidative stress (e.g. Cdkn1b, Tmem27, Pax6,
Cat, Prdx4 and Txnip). In addition, pathway analysis
identified oxidative phosphorylation as the predominant
gene-set that was significantly upregulated in response to
the diabetogenic HF diet.
Conclusions/interpretation We demonstrated that LCM of
pancreatic islet cells in combination with transcriptional
profiling can be successfully used to identify novel
candidate genes for diabetes. Our data strongly implicate
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Introduction
The prevalence of type 2 diabetes and obesity has
dramatically increased in recent years, driven by changes
in environment and lifestyle interacting with genetic
susceptibility. Recent genome-wide association studies
(GWAs) in large cohorts of patients with type 2 diabetes
and obesity have revealed multiple new candidate genes for
these metabolic diseases [1]. Interestingly, all of the
susceptibility genes for obesity strongly implicate a role
for the brain, whereas most of the diabetes susceptibility
genes play a role in insulin secretion and beta cell function.
However, these genes explain only a small portion of the
individual risk of diabetes, and it is likely that there are
more candidate genes not detected by current methodology.
Inbred mouse models have been used extensively to
identify genetic risk factors for obesity and type 2 diabetes
[2, 3]. Chronic hyperglycaemia is the main feature in the
diabetic state, and glucotoxicity has been implicated as
playing an important role in the development of type 2
diabetes [4]. Several different mechanisms have been
proposed to explain the negative effects of chronic hyper-
glycaemia [5]. For instance, it has been proposed that
elevated glucose levels lead to cellular stress, which might
damage insulin-producing beta cells [6]. Nevertheless, the
significance of data from transcriptional studies of islet
cells is limited, since the arduous conventional collagenase
digestion protocol for procuring pancreatic islets is known
to alter gene expression patterns as observed in collagenase-
isolated primary adipose cells [7–9]. In fact, collagenase
digestion has been reported to induce a marked increase in
expression of proinflammatory genes and of genes involved
in hypoxia-induced stress and apoptosis, respectively, i.e.
the very same pathways that have been implicated in the
pathophysiology of glucose-induced beta cell death [8]. We
recently introduced the New Zealand obese mouse (NZO)
mouse strain as a suitable disease model for studying the role
of dietary carbohydrates in the pathophysiology of high fat-
diet induced diabetes [10]. In this model, a carbohydrate-
containing high-fat diet (HF) is highly diabetogenic whereas
a carbohydrate-free high-fat diet (CHF) protects from
diabetes [10]. In the present study we isolated authentic
pancreatic islets with laser capture microdissection (LCM)
and performed genome-wide expression analyses with
samples from HF- and CHF-treated animals. Our results
support the concept that glucose-induced oxidative stress in
islets is relevant for disease progression.
Methods
Experimental animals Up to six male New Zealand (NZL)/
LtJ mice (The Jackson Laboratory, Bar Harbor, MA, USA)
were housed per cage (macrolon type III) at a temperature
of 22°C with a 12 h light–dark cycle (lights on at
06:00 hours). The animals were kept in accordance with
the NIH guidelines for the care and use of laboratory
animals and all experiments were approved by the Ethics
Committee of the State Ministry of Agriculture, Nutrition
and Forestry (State of Brandenburg, Germany). After
weaning at 3 weeks, the animals received either a HF diet
(10105721; Altromin, Lage, Germany) (14.6% [wt/wt] fat,
46.8% carbohydrates, 17.1% protein) or a CHF diet
(10105789; Altromin) (30.2% [wt/wt] fat, 0% carbohy-
drates, 26.4% protein) diet. Throughout the study the
animals had free access to food and water.
Analysis of body composition Body composition and body
weight were measured weekly. Body composition was
measured by nuclear magnetic resonance (Echo MRI Whole
Body Composition Analyzer; Echo Medical Systems,
Houston, TX, USA).
Blood glucose and plasma insulin Blood glucose was
measured weekly under non-fasting conditions in blood
samples collected from the tail vein with a blood glucose
meter (Ascensia Elite; Bayer Health Care, Leverkusen,
Germany). Insulin levels were determined by ELISA
(insulin mouse ultra-sensitive ELISA; DRG Instruments,
Marburg, Germany).
Glucose tolerance tests At 8 weeks, animals were fasted for
16 h before the experiment. Each animal received a single
i.p. injection of glucose (20% solution, 2.0 g/kg body
weight). Samples for determination of blood glucose and
plasma insulin concentration were collected at 0, 7.5, 15,
30, 60, 120 and 240 min from the tail tip. Mice were kept in
their accustomed cage and had free access to water.
Quantitative real-time PCR Isolated islet RNA (20–50 ng)
was amplified with a whole transcriptome amplification kit
(TransPlex; Sigma-Aldrich, Seelze, Germany). The ampli-
fied cDNAwas purified with a PCR clean-up kit (GenElute;
Sigma-Aldrich). Quantitative real-time PCR was performed
with the 7300 Real-Time PCR System (Applied Biosys-
tems, Darmstadt, Germany). The PCR mix (25 µl) was
310 Diabetologia (2010) 53:309–320composed of TaqMan universal PCR Master Mix (10 µl;
Applied Biosystems), TaqMan-Probe (1 µl; Applied
Biosystems) and 10 ng of cDNA per reaction. Relative
gene expression was calculated by the ∆∆Ct method with
Actb as control gene [11]. Expression differences be-
tween groups were tested with Mann–Whitney–Wilcoxon
test. p values below 0.05 were considered statistically
significant.
Laser capture microdissection and total RNA isolation
Pancreatic sections were prepared at 14 µm thickness using
a cryostat (Leica, Wetzlar, Germany) and mounted on
RNase-free membrane-coated slides (P.A.L.M., Wolfrat-
shausen, Germany). Immediately before microdissection,
sections were fixed in ethanol and then rehydrated in 75%
and 50% ethanol (vol./vol.) for 30 s each. Sections were
stained with filtered cresyl violet acetate (Ambion) for
1 min to allow for identification of islets. Next, sections
were dehydrated with a graded alcohol series (50%, 75%
and 100 % and 100% (vol./vol.), 30 s each). Finally, the
slides were placed in HistoClear (National Diagnostics,
Atlanta, GA, USA) for 2 min and left to air-dry under the
hood. Out of ten evenly spaced Nissl-stained sections, 500
islets were dissected using a LCM system (P.A.L.M.).
Samples were stored in 20 µl of RNAlater (Ambion). Total
RNA was isolated from the LCM samples using an RNA
extraction kit (RNAqueous Micro; Ambion) following the
manufacturer’s instructions. RNA concentrations were
determined using a spectrophotometer (NanoDrop ND-
1000; Thermo Scientific, Wilmington, DE, USA). Quality of
the RNA was determined with BioAnalyzer 2100 (Agilent,
Böblingen, Germany). The RNA integrity value was used as
an indicator of RNA quality. Only samples with a RNA
integrity value over 4.5 were used for further analysis.
Analysis of the coefficients of variation of biological replicate
hybridisations confirmed homogenous RNA preparations of
sufficient quality for microarray experiments (Electronic
supplementary material [ESM] Fig. 1).
Amplification and labelling of LCM-isolated islet RNA For
labelling of the isolated islet RNA we used an RNA
amplification system (WT-Ovation Pico; NuGEN, San
Carlos, CA, USA) with 100 ng RNA per reaction to
produce labelled cDNA.
Hybridisation of Affymetrix microarrays For genome-wide
transcriptome analysis, we used the Affymetrix Mouse
Genome 430 2.0 Array platform (www.affymetrix.com/
products_services/arrays/specific/mouse430_2.affx; version
09.01.2008). LCM-isolated islets from each mouse were
processed separately. Labelled cDNA (5 µg) was hybridised
on to each array. We analysed NZL samples from isolated
islets and total pancreas with respect to two nutritional
conditions induced by the HF and CHF diets.
Data processing The pre-processing and analysis of the
microarray data was performed with the R/BioConductor
software platform [12]. Arrays for each individual case–
control study were normalised using the GC RMA method
[13]. Affymetrix gene chip annotations were adapted from
latest genome annotations inversion9,basedonEnsembl42,
and resulting in 15,758 Ensembl genes [14]. Additional
annotation for the Ensembl genes is based on Ensembl 46.
Presence tags were calculated following Affymetrix proce-
dures. For quality control, we analysed the coefficient of
variation of the raw probe fluorescence intensities for all
biological replicates in the hybridisation experiments (ESM
Fig. 1). Differential expression was judged by three criteria:
(1) the gene is expressed in at least one of the samples,
treatment or control. at p≤0.05; (2) the fold-change is >4/3 or
<3/4; and (3) the Welsh test p value is p<0.05.
Identification of disease-related networks using enrichment
analyses Disease-related networks were investigated with
two different types of functional information: (1) biological
pathways [15] as provided by the KEGG database (www.
genome.jp/kegg/; version 09.01.2008); and (2) functional
categories using Gene Ontology annotations (Ensembl 41)
[16]. These functional information terms define groups of
associated genes. Using enrichment analyses with hyper-
geometric distribution [17], we were able to assign each
annotation term a p value that reflects enriched occurrence
of differentially expressed genes. In case of Gene Ontology
terms, we included only genes with evidence codes inferred
from direct assay (IDA), mutant phenotype (IMP), traceable
author statement (TAS) or by curator (IC) in order to ensure
a high confidence level.
Immunohistochemistry Pancreatic tissue was fixed in 4.5%
(w/v) formaldehyde and embedded in paraffin according to
standard procedures. Sections (2 µm) were stained with
haematoxylin. Endogenous peroxidase activity in the
sectioned tissues was blocked with 3% (v/v)H 2O2 and
non-specific binding sites were blocked with non-immune
goat serum. Subsequently, rabbit polyclonal antibody to
carbohydrate-responsive element binding protein
(ChREBP; 1:500; GeneTex, Irvine, CA, USA) was applied
and stained with biotin-conjugated donkey anti-rabbit IgG
and streptavidin–biotin–horseradish peroxidase complex
(Dianova, Hamburg, Germany) and diaminobenzidine
(Dako Diagnostika, Hamburg, Germany) as substrate
according to the manufacturer’s instructions. A ChREBP
antibody/peptide complex (aa 800-852; NP_116569; Gen-
eTex) served as control for non-specific binding.
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A carbohydrate-free high-fat diet protects from hyper-
glycaemia and beta cell failure Male NZL mice were
raised on two different diets, namely HF (35% calories
from fat) and CHF (72% calories from fat). As illustrated in
Fig. 1a, the body weight of the animals was similar on both
diets, reaching approximately 55 g in week 17. NZL mice
also developed a similar degree of obesity on both diets,
with fat depots reaching 36% of total body weight (∼18 g
total body fat; Fig. 1b). However, whereas most animals on
the HF developed severe hyperglycaemia beginning at
week 8, with blood glucose levels progressively increasing,
animals on the CHF maintained normal glycaemia until the
end of the dietary intervention (Fig. 1c, ESM Fig. 2). At
week 8, animals from both diet groups displayed severe
glucose intolerance and, as described earlier [18], a
markedly blunted early-phase secretion of insulin in response
to a glucose bolus (Fig. 1e). At week 17, the prevalence of
diabetes (blood glucose levels >13.88 mmol/l) in HF mice
was 63%. In contrast, no incidence of diabetes was observed
in the CHF group (ESM Fig. 2).
Enrichment of transcripts in islets To assess the effective-
ness of our islet isolation procedure, we performed quantita-
tive real-time PCR with cDNA derived from laser-captured
isletsandcDNAfromwhole pancreaspreparations.Asshown
in Fig. 2, the cDNAs for the islet-specific glucose transporter
Slc2a2, Foxo1 and Gcg were enriched in islet preparations.
To obtain a profile of global transcript abundance in islets,
we compared whole-genome expression data from islets of
8-week-old CHF-fed mice with data obtained by hybrid-
isation of RNA from total pancreas of matched animals. As
expected, the list of the most abundant transcripts in islets
included insulin, glucagon, islet amyloid polypeptide, car-
boxypeptidase E and other well established genes expressed
in alpha and beta cells (ESM Table 1). Transcripts required
for protein synthesis, protein secretion and oxidative phos-
phorylation were also highly abundant in the isolated islets.
In contrast, the highest expression levels in total pancreas
were observed for hydrolytic enzymes, including pancreatic
proteases, lipases and nucleases (data not shown). To identify
islet-specific transcripts, we calculated a simple enrichment
score by dividing the median-normalised fluorescence
intensities from islet and pancreas samples for each
transcript. Of the ∼10,000 genes expressed, we identified
238 transcripts that were highly enriched (≥ tenfold) in islets
vs total pancreas (ESM Table 2). The list of enriched
transcripts includes numerous well-known genes thought to
play critical roles in islet functions such as insulin production
(e.g. Cpe, Pcsk1, Pcsk2) and secretion (e.g. Abcc8, Ucn3,
Glp1r, Sst, Slc2a2, Snap25), and cell growth and differen-
Fig. 1 A CHF diet protects
from hyperglycaemia and
diabetes. a Body weight of
17-week-old male NZL mice fed
either HF or CHF. b Body fat
content. c Blood glucose levels
at week 17. d Plasma insulin
levels at week 22. Values were
derived from 14 to 16 animals
per group. e Intraperitoneal
glucose tolerance test at week 8,
five animals per group. Values
are mean±SE. White circles,
CHF plasma glucose; black
circles, HF plasma glucose;
white squares, CHF plasma
insulin; black squares, HF
plasma insulin
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associated with type 2 diabetes in recent human genome-
wide scans (Wfs1, Slc30a8; ESM Table 2). Conversely, ∼400
transcripts were highly enriched (≥ tenfold) in total pancreas
vs islets, including the well-known pancreatic hydrolases,
Cckar and members of the Reg gene family, all three of
which have been implicated in islet cell regeneration (data
not shown). However, expression of transcripts derived from
exocrine pancreatic cells was greatly reduced in islet
preparations (ESM Table 3). Yet, for a number of genes
with robust islet-selective expression, the biological function
is unknown.
Comparison with GWAs for type 2 diabetes Over recent
years, GWAs have revealed numerous genetic loci, some of
which have been implicated in the pathogenesis of diabetes,
insulin secretion and beta cell survival. To determine how
successful our approach was in identifying plausible novel
candidates, we compared differentially expressed genes
from our mouse model for diet-induced diabetes with
previously reported single nucleotide polymorphisms
(SNPs) associated with type 2 diabetes in humans. We
used data from two publicly available genome-wide scans,
the Diabetes Genetics Initiative (DGI) study [19] and the
Wellcome Trust Case Control Consortium (WTCCC) GWA
for diabetes [20]. We compiled a list of 837 SNPs that map
to 439 known human genes and are nominally associated
with diabetes (p<0.05) in both scans. Of the 430 mouse
orthologue genes, 39 mouse genes were differentially
expressed ≥1.5-fold) in our study (Table 1, ESM Fig. 3).
Interestingly, the list includes two genes from genetic loci
found to be associated with diabetes in recent GWAs,
IGF2BP2 [20, 21] and TSPAN8-LGR5 [22], as well as
CACNA1D, which is required for pancreatic beta cell
generation in mice [23]. We selected nine differentially
expressed genes and performed quantitative real-time PCR
with RNA from LCM-isolated islets and with RNA from
total pancreas. As illustrated in ESM Fig. 4, we were able
to validate all five selected genes that were downregulated
by the HF, including Dach1, Clip2, Cacna1d, Igf2bp2 and
Chd2. In contrast, we were not able to confirm HF-induced
upregulation of Ldlrad3, Sil1, Plekha1 and Pdia3 by
quantitative real-time PCR.
Diet-dependent differentially expressed genes We identified
3,027 differentially expressed genes in islets of HF- and
CHF-fed NZL mice. Of those, 2,109 genes showed at least
1.5-fold changes in gene expression, with 1,496 genes
upregulated and expression of 613 genes decreased in
response to the HF. We categorised the top 50 differentially
expressed genes according to their known or putative
biological function and grouped these genes into the
following categories of genes involved in: (1) growth and
development; (2) protein processing and secretion; (3)
metabolism; and (4) signalling (Table 2). In the islets, HF
induced gene expression changes associated with increased
cell cycle progression, proliferation and differentiation,
such as Cdkn1b, Tmem27 and Pax6 (Table 2). Also, several
genes involved in insulin production and secretion were
differentially regulated by the HF, such as Pcsk1 and Pcsk2
(Table 2). Moreover, known regulators of the cellular redox
state such as Txnip, Cat, Gpx1 and Prdx1 to Prdx5 were
increased up to fourfold in the islets of HF-fed animals
(Table 2). From each of the four functional categories,
growth and development, protein processing and secretion,
metabolism, and signalling, we selected one to two
differentially expressed genes and performed quantitative
real-time PCR with RNA from LCM-isolated islets and
RNA from total pancreas. As illustrated in Fig. 3, diet-
induced changes in expression levels for Cacna1d, Cck,
Mlxipl, Txnip and Tmem27 were validated by quantitative
real-time PCR in LCM islets. However, the mRNA levels
for Cacna1d, Mlxipl, Txnip and Tmem27 were not or only
slightly changed by the diet in RNA from total pancreas,
indicating that differential expression was restricted to islet
cells (data not shown). Moreover, mRNA for Cck (HF-Ct
value in islets ∼25) was not detected in total pancreas.
Interestingly, islet mRNA for Chrebp (also known as
Mlxipl), a transcription factor that has emerged as a key
determinant of lipid synthesis and a major mediator of
hepatic conversion of glucose into fat [24], was also
significantly decreased in response to the diabetogenic HF
(Table 2), a finding validated by quantitative real-time PCR
(Fig. 3). Immunohistochemical staining of pancreatic
sections from NZL and C57BL/6J mice confirmed
Fig. 2 Enrichment of selected islet genes in LCM samples. mRNA
expression genes was determined by quantitative TaqMan RT-PCR for
each gene and for Actb from LCM islets (white bars) and total
pancreas (black bars) of 8-week-old mice. Expression levels are
presented as change in Ct or the cycle number of each gene subtracted
from the cycle number of beta-actin (Ct value 20.15) for the same
cDNA sample. Lower numbers thus correspond to higher expression.
Data are means±SE from five CHF-fed NZL mice. *p≤0.05
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Abcc4 1.789 1.59 rs1751052 1.179 0.026 0.018
g
Arhgap24 1.516 1.170 rs12640411 0.855 0.027 0.025
g
rs12506596 0.846 0.018 0.024
g
rs12644260 0.844 0.019 0.038
g
rs4693716 0.849 0.023 0.026
g
rs1384135 0.842 0.016 0.027
g
rs1384134 0.840 0.017 0.026
g
rs9884932 0.845 0.018 0.025
g
rs10000472 0.845 0.018 0.026
g
rs17389300 0.848 0.020 0.024
g
Cacna1d
h 0.522 2.70 rs12487452 0.796 0.018 0.024
g
Camkk2 0.515 2.96 rs9805130 0.841 0.004 0.044
g
Car8 1.771 1.13 rs10216440 0.833 0.026 0.001
g
Chd2
h 0.532 21.00 rs1406712 1.379 0.039 0.023
g
Clip2
h 0.435 7.91 rs2528994 1.118 0.020 0.021
g
rs512023 1.098 0.029 0.042
g
Cobll1 2.348 0.19 rs6717858 0.892 0.027 0.026
g
Ctnnd2 1.877 9.39 rs6873671 1.138 0.025 0.034
i
Esyt2 1.602 0.47 rs3816465 1.198 0.037 0.009
i
rs6873490 1.137 0.019 0.030
i
Dach1
h 0.352 8.78 rs7991293 1.469 0.019 0.010
i
Elf1 1.855 0.24 rs9525438 1.143 0.034 0.018
i
rs7799 1.143 0.028 0.005
i
rs9532691 1.148 0.024 0.007
i
Fam45a 1.571 0.60 rs4752250 0.856 0.043 0.005
g
rs11198783 0.837 0.015 0.005
g
Gnaq 1.541 0.93 rs6560613 0.777 0.034 0.007
g
rs4745664 0.839 0.024 0.040
g
H2-Ea 1.806 0.41 rs7194 0.872 0.041 0.045
g
Hnrnpc 1.582 0.87 rs17092523 0.936 0.033 0.001
i
rs4982437 0.914 0.021 0.010
i
rs7495 0.929 0.028 0.005
i
rs8009894 0.941 0.046 0.006
i
rs7141230 0.938 0.039 0.004
i
rs7147655 0.935 0.036 0.007
i
Igf2bp2
h 0.493 5.74 rs4402960 1.110 0.034 0.002
g
rs7651090 1.103 0.039 0.002
g
Igf2r 1.904 1.24 rs10945645 0.780 0.007 0.039
i
rs3798197 0.869 0.028 0.032
i
rs9295119 0.836 0.040 0.012
i
Inpp5d 0.588 2.51 rs10176895 0.7583 0.043 0.025
g
rs10189488 0.735 0.018 0.035
g
rs10200271 0.7084 0.022 0.045
g
Klhl21 1.688 1.22 rs1556036 1.122 0.031 0.008
i
Ldlrad3 5.274 3.56 rs12361738 0.869 0.020 0.023
g
Lyar 1.52 0.158 rs2980089 1.217 0.016 0.05
g
Mphosph6 1.941 0.96 rs1862820 1.201 0.009 0.004
g
314 Diabetologia (2010) 53:309–320presence of ChREBP protein in islet cells (Fig. 4a–d),
although we were unable to quantify its nuclear local-
isation. According to quantitative real-time PCR analysis,
expression of Chrebp mRNA was comparable in liver and
islet tissue. However, only in the liver of the animals, did
the HF result in substantial upregulation of Pklr, Scd1 and
malic enzyme, whereas no significant changes in gene
expression levels were observed in the corresponding islets
of the animals (Fig. 4e).
Pathway analysis The set of differentially expressed genes
was used to perform pathway analysis as described. Gene
set enrichment of the most significant KEGG pathways
revealed differential expression of genes involved in
mitochondrial oxidative phosphorylation, proteasome, ribo-
some, pyruvate metabolism, terpenoid biosynthesis, N-
glycan biosynthesis, bisphenol A degradation and reductive
carboxylate cycle (Table 3, ESM Table 4). Oxidative
phosphorylation was the most significantly over-represented
Table 1 (continued)








Nampt 1.584 0.48 rs4730155 0.909 0.043 0.012
g
Pdia3 3.384 0.50 rs8040336 0.852 0.012 0.045
g
Pdlim5 0.561 4.80 rs6830074 0.804 0.047 0.003
g
rs6812098 0.790 0.041 0.015
g
Phactr1 0.525 33.9 rs17617584 0.770 0.027 0.048
g
rs9296486 0.794 0.009 0.043
g
rs9296488 0.799 0.011 0.032
g
rs9349350 0.802 0.012 0.023
g
rs9357503 0.837 0.033 0.028
g
rs9381439 0.804 0.013 0.035
g
Ppfia3 0.6 4.41 rs3764625 1.132 0.023 0.003
g
Pkib 2.289 1.52 rs17084680 1.085 0.025 0.614
g
Plekha1 2.424 0.51 rs17103541 1.303 0.023 0.028
g
Qpct 3.93 0.52 rs2255991 1.368 0.029 0.01805
g,i
Sil1 1.951 0.57 rs1560656 0.871 0.022 0.042
i
Stxbp6 1.825 0.19 rs17257773 1.352 0.006 0.024
i
Tacr3 2.138 1.27 rs1384401 0.828 0.011 0.015
g
rs5005634 0.835 0.011 0.011
g
rs7663664 0.821 0.009 0.010
g
Tmem135 1.766 0.72 rs10898589 1.428 0.018 0.044
g
rs10898590 1.449 0.013 0.009
g
Tspan8 3.993 1.35 rs10506625 0.860 0.019 0.00007
g
rs10506626 1.146 0.015 0.00002
g
rs11178648 1.158 0.014 0.00005
g
rs2270584 1.146 0.012 0.00002
g
Ube2z 1.759 0.94 rs15563 0.903 0.031 0.028
i
rs46522 0.906 0.040 0.025
i
rs1994970 0.907 0.040 0.033
i
rs4793992 0.904 0.043 0.029
i
Xkr6 0.537 3.11 rs7016385 1.115 0.033 0.019
g
Expression of genes was determined with mRNA from LCM islets and from total pancreas of 8-week-old mice
aOnly genes with a significant fold-change (p≤0.05) were included
bRatio of median-normalised fluorescence intensities from islet and pancreas samples for each transcript
cOnly SNPs with p≤0.05 in both GWAs [19, 20] were included
d,eOdds ratios and p values for association with type 2 diabetes in DGI study
fAs above (
d,e) in WTCCC Study
gAdditive model;
hdifferential expression validated by quantitative real-time;
igeneral model
Diabetologia (2010) 53:309–320 315Table 2 Diet-dependent differentially expressed genes in islets
Symbol per category Description Ratio (HF/CHF)
a
Growth and development
Pax6 Paired box gene 6 0.51
Cdkn1b Cyclin-dependent kinase inhibitor 1B 0.40
Pura Purine rich element binding protein A 0.37
Dach1 Dachshund 1 (Drosophila) 0.35
Metabolism
Gmds GDP-mannose 4, 6-dehydratase 5.02
Ndufa1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 4.80
Sqle Squalene epoxidase 4.64
Atp5b ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit 4.40
Prps1 Phosphoribosyl pyrophosphate synthetase 1 4.23
Suclg1 Succinate-CoA ligase, GDP-forming, alpha subunit 4.14
Pon3 Paraoxonase 3 4.13
Scd1 Stearoyl-Coenzyme A desaturase 1 2.80
Pfkfb2 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 0.41
Cyp4a10 Cytochrome P450, family 4, subfamily a, polypeptide 10 0.35
Chkb Choline kinase beta 0.34
Eno3 Enolase 3, beta muscle 0.34
Mlxipl MLX interacting protein-like 0.29
Gmds GDP-mannose 4, 6-dehydratase 0.20
Protein processing and secretion
Rps27l Ribosomal protein S27-like 5.05
Psmb7 Proteasome (prosome, macropain) subunit, beta type 7 4.85
Vamp8 Vesicle-associated membrane protein 8 3.15
Pcsk1 Proprotein convertase subtilisin/kexin type 1 2.73
Pcsk2 Proprotein convertase subtilisin/kexin type 2 1.92
Vti1b Vesicle transport through interaction with t-SNAREs 1B homologue 1.88
Vamp5 Vesicle-associated membrane protein 5 0.40
Sec24a SEC24 related gene family, member A (S. cerevisiae) 0.38
Signalling
Cck Cholecystokinin 9.25
Rheb RAS-homologue enriched in brain 4.82
Dusp6 Dual specificity phosphatase 6 4.26
Cacna1d Calcium channel, voltage-dependent, L type, alpha 1D subunit 0.52
Rps6kb2 Ribosomal protein S6 kinase, polypeptide 2 0.40
Nlgn1 Neuroligin 1 0.34
Vipr1 Vasoactive intestinal peptide receptor 1 0.33
P2ry6 Pyrimidinergic receptor P2Y, G-protein coupled, 6 0.28
Regulation of redox status
Txnip Thioredoxin interacting protein 4.14
Prdx4 Peroxiredoxin 4 3.10
Prdx5 Peroxiredoxin 4 2.74
Cat Catalase 1.95
Gpx1 Glutathione peroxidase 1 2.26
Other
Ctss Cathepsin S 12.98
Cldn11 Claudin 11 11.32
Spp1 Secreted phosphoprotein 1 4.55
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regulated between HF and CHF. About half of the genes
annotated for oxidative phosphorylation (OXPHOS), protea-
some and ribosome were differentially expressed in islets in
response to the dietary regiment. In fact, the majority of these
genes annotated for these three pathways were upregulated in
response to HF (Table 3). To confirm this observation, we
performed quantitative real-time PCR on six OXPHOS
genes that are derived from complex I (Ndufa8, Ndufb9
and Ndufc2) and on one from each of complexes II, III and
IV (Sdhd, Uqcrc2 and Cox5a, respectively). With the
exception of Uqcrc1 from complex III, each transcript was
upregulated in response to HF, with significant changes for
Ndufa8, Ndufb9 and Ndufc2 (Fig. 5).
Discussion
To identify potentially relevant candidate genes involved in
type 2 diabetes, we used a model of beta cell failure, NZL
mice, fed either a HF or a CHF diet. To gain insights into
the pathophysiology of diet-induced beta cell failure and the
metabolic pathways mediating downstream effects of the HF,
we isolated pancreatic islets with LCM and performed
genome-wide expression analyses. Consistent with previous
findings [10, 25], our data clearly demonstrate the critical
Fig. 4 Islet levels of ChREBP and regulation of lipogenic target
genes. Immunohistochemical detection of ChREBP in pancreatic
sections from male NZL mice. HF (a) and CHF fed (b) animals at
week 8, with (c, d) respective controls with blocking peptide.
e TaqMan quantitative PCR validation of ChREBP target genes in
islets. Values are normalised to Actb. Data are mean±SE of five
separate mice per group; *p≤0.05. White bars, CHF; black bars, HF;
grey bars, CHF liver; hatched bars, HF liver. Srebp-1 is also known as
Srebf1
Fig. 3 Validation of differential expression in islets by quantitative
real-time PCR. TaqMan quantitative PCR validation of genes
differentially regulated between CHF (white bars) and HF (black
bars). The change in expression is shown for selected genes involved
in islet growth and development, protein processing and secretion,
metabolism, and signalling. Values are normalised to Actb. Data are
mean ± SE of five separate mice per group. *p≤0.05
Table 2 (continued)
Symbol per category Description Ratio (HF/CHF)
a
Alg5 Asparagine-linked glycosylation 5 homolog 4.54
Tmem27 Transmembrane protein 27 1.94
The top 44 differentially expressed genes (HF vs CHF) were categorised according to their known or putative biological function
aMean of five to six Affymetrix chips per condition; only genes with a significant fold-change were included (p≤0.05)
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fat-diet induced diabetes. In the obese NZL mice as well as
the related NZO strain, a CHF protects from hyperglycaemia
and beta cell failure, whereas a carbohydrate-containing HF
diet is highly diabetogenic [10]. Since both diets induce a
similar degree of adiposity and glucose intolerance, the beta
cell toxicity is likely to be due to elevated glucose
concentrations.
As expected, numerous genes known to be highly
expressed in islets, such as insulin, glucagon and islet
amyloid polypeptide, were also highly abundant in the
LCM samples. In fact, about 2.5% of all transcripts
expressed were highly enriched in islets cells compared
with total pancreas. Moreover, many of those transcripts
have not been linked to islet cell function previously and
may therefore represent novel candidate genes with relevant
functions in islet cell biology. Most importantly, however,
islet RNA isolated with LCM is likely to reflect the
transcriptome of these cells more accurately, compared
with the conventional collagenase-digestion method used
for islet isolation [7, 8]. In fact, the latter procedure has
been reported to induce marked increases in gene expres-
sion of proinflammatory genes and of genes involved in
hypoxia-induced stress and apoptosis, thereby severely
impairing interpretation of expression data derived from
metabolically stressed islet cells [7, 8]. Thus, LCM
represents an ideal tool to obtain native islet samples
without inducing the stress-response of islet isolation.
Recent GWAs have revealed numerous genetic loci
associated with type 2 diabetes in humans [1]. So far, there
has been a lack of functional data about the involvement of
these variants in the pathogenesis of diabetes. However,
most of these genes were found to be highly expressed in
islets [1]. We identified 39 genes that are highly expressed
in the pancreas and were differentially expressed in our
mouse model of diet-induced diabetes and nominally
associated with diabetes in two independent GWAs, the
DGI study and the WTCCC scan for diabetes, respectively
[19, 20], thus validating our approach (Table 1). Among
these genes is CACNA1D, the voltage-dependent calcium
channel, which has been shown to be required for
pancreatic beta cell generation in mice [23]. Interestingly,
the list also includes two loci that have been found to be
associated with type 2 diabetes in recent GWAs, IGF2BP2
[19, 21] and TSPAN8-LGR5 [22]. With regard to the latter
region, the most significant association with type 2 diabetes
in a meta-analysis of three GWA scans was observed for
rs7961581 (p=1.1 × 10
−9), which maps in the intergenic
region between TSPAN8 and LGR5 [22]. In mouse islet
cells, the diabetogenic HF increased expression of Tspan8
approximately fourfold, whereas Lgr5 expression was not
changed (Table 3, data not shown). Thus, our data provide
evidence that TSPAN8 is more likely to be functionally
related to the development of type 2 diabetes than LGR5. It
should be mentioned, however, that our approach has
limitations, since we only took into account the two
publicly available genome-wide scans on type 2 diabetes
susceptibility genes. Moreover, the overlap of differentially
Fig. 5 TaqMan quantitative PCR validation of OXPHOS genes in
islets. The changes in expression of selected OXPHOS genes are
shown. Values are normalised to Actb. Data are mean±SE of five
separate mice per group; *p≤0.05. White bars, CHF; black bars, HF
Table 3 Gene set enrichment analysis of 3,027 genes differentially regulated by HF and/or CHF diet in islets






−12 96 49 46 3
Proteasome 1.41×10
−7 25 17 17 0
Ribosome 0.00297 21 10 9 1
Pyruvate metabolism 0.00639 37 14 12 2
Terpenoid biosynthesis 0.00708 3 3 2 1
N-Glycan biosynthesis 0.00836 38 14 13 1
Bisphenol A degradation 0.0085 17 8 6 2
Reductive carboxylate cycle 0.0095 11 6 6 0
Only pathways with significant changes (p≤0.01) were included
aNumber of genes in KEGG pathway;
bdifferentially expressed genes
318 Diabetologia (2010) 53:309–320expressed genes in islets and genes found in the two GWAs
amounts roughly to the number expected by chance.
However, this number is likely to be underestimated,
because not all genes were tested for association with type
2 diabetes in the merged scans.
Exposure to HF resulted in a substantial number of
differentially expressed genes in the islets, reflecting
prominent changes of the expression pattern in response
to the diet. In fact, the majority of these genes (>80%) were
upregulated in HF islets. We have previously shown that in
the prediabetic state, HF induces massive hyperglycaemia
in the related NZO strain and compensatory hyperplasia of
pancreatic islets [10, 26, 27]. Consistent with these data,
HF induced gene expression changes associated with
increased islet growth and insulin production, such as
increased expression of Tmem27, the proapoptotic
thioredoxin-interacting protein Txnip, Cck and Pcsk2, and
downregulation of Cacna1d [23, 28–30].
Most strikingly, genes for OXPHOS were substantially
upregulated by the HF, demonstrating enhanced oxidative
metabolism in islets of animals receiving HF or high-
carbohydrate diet. Moreover, the majority of enzymes for
pyruvate metabolism and TCA cycle were significantly
upregulated by the HF, suggesting an increased flux of fatty
acid-derived acyl-CoA towards mitochondrial oxidation in
the presence of dietary carbohydrates. Thus, increased
availability of carbohydrates stimulates oxidative metabo-
lism in islets, presumably by providing sufficient TCA
intermediates in the mitochondrial matrix (anaplerosis).
Alterations in expression of OXPHOS genes has been
regarded as a key change in the insulin-resistant state in
human patients and animal models of type 2 diabetes [31–
33]. Since OXPHOS is a major source of reactive oxygen
species (ROS) production, increased mitochondrial oxygen
flux leads to increased formation of ROS [34–37]. ROS
include highly reactive moieties, such as superoxide anions,
hydrogen peroxide and hydroxyl radicals, which have been
implicated in the pathogenesis of diabetes [38, 39].
Consistent with elevated ROS production in HF islets, the
gene expression of regulators of the cellular redox state,
including catalase, glutathione peroxidase 1, peroxiredoxins
and thioredoxin interacting protein, was increased, strongly
implicating ROS in the early state of beta cell failure.
Proteomic analysis of isolated islets may be used to further
investigate the diet-induced alterations in OXPHOS gene
expression and protein modifications in response to
increased oxidative stress.
Among the most differentially expressed genes in
response to the dietary intervention were the transcription
factor Chrebp and the peptide hormone Cck. Interestingly,
cholecystokinin mRNA, which was upregulated about
tenfold by the HF, appears to be highly enriched in LCM
islets. Recent evidence suggests that cholecystokinin acts as
a proliferative signal on beta cells [28], implicating it in the
compensatory hyperplasia of islet cells in the prediabetic
state. ChREBP has been described as a transcriptional sensor
forglucoseintheliver,whichbecomesactivateduponglucose
stimulation and triggers production of lipogenic enzymes for
conversion of glucose into fat [24]. We confirmed ChREBP
protein production in islets by immunohistochemistry
(Fig. 4a–d). Moreover, Chrebp mRNA levels in islets and
liver were comparable (Fig. 4e). Consistent with previous
reports [24], HF-induced hyperglycaemia resulted in
activation of ChREBP in the liver and subsequent
induction of lipogenic enzymes, including acetyl-CoA
carboxylase, fatty acid synthase, stearoyl-CoA desaturase
1 and liver-type pyruvate kinase (Fig. 4e and data not
shown). Interestingly, in islets, ChREBP was considerably
decreased in response to the diabetogenic HF, whereas
transcription of ChREBP target genes was not affected,
clearly indicating that in islets ChREBP controls different
target genes than in the liver. In fact, a recent report
demonstrated that ChREBP mediates glucose-induced
expression of proapoptotic Txnip and induces H4 acetyla-
tion in beta cells, implicating a wider role of ChREBP
beyond regulation of hepatic enzymes [40].
In summary, our data clearly demonstrate the critical role
of dietary carbohydrates in the pathophysiology of HF-
induced diabetes. LCM allows isolation of authentic
pancreatic islet cells from their native tissue environment
for genome-wide expression profiling. In islets, the
diabetes-protective effect of a CHF diet correlates with
reduced expression of genes for OXPHOS and antioxi-
dants, suggesting a major contribution of ROS to diet-
induced beta cell failure. Thus, our approach successfully
identified candidate pathways and molecules that may play
a role in the aetiology of type 2 diabetes.
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